GIA
ENTX icon

Gem Investment Advisors’s Entera Bio ENTX Stock Holding History

Gem Investment Advisors’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.9K Hold
19,135
– – 0.02% 36
2026
Q1 		$21.2K Hold
19,135
– – 0.02% 34
2025
Q4 		$37.1K Buy
+19,135
New +$44.9K 0.04% 31

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Gem Investment Advisors's ENTX Position: Q2 2026 in Review

Gem Investment Advisors held its Entera Bio (ENTX) position steady in Q2 2026 at 19,135 shares worth $33.9K. The position accounts for 0.02% of the portfolio, ranked #36.

Gem Investment Advisors first reported a position in ENTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $37.1K in Q4 2025. 27 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Gem Investment Advisors held 19,135 shares of Entera Bio worth $33.9K as of Q2 2026.
  • Gem Investment Advisors left its Entera Bio share count unchanged in Q2 2026.
  • Entera Bio made up 0.02% of Gem Investment Advisors's portfolio in Q2 2026, its #36 holding.
  • Gem Investment Advisors first reported a position in Entera Bio in Q4 2025 and has held it in 3 quarters since.
  • Gem Investment Advisors's Entera Bio position peaked at $37.1K in Q4 2025.
  • 27 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Gem Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.